Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
China flag China · Delayed Price · Currency is CNY
50.78
-0.62 (-1.21%)
Feb 13, 2026, 3:04 PM CST

SHE:002294 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
56,61034,48135,64436,22530,22029,138
Market Cap Growth
67.42%-3.26%-1.60%19.87%3.71%39.70%
Enterprise Value
54,59132,68833,89833,15427,01728,494
Last Close Price
50.7830.5331.6631.4125.6326.58
PE Ratio
84.6057.3261.4556.8656.62478.73
Forward PE
84.3551.5558.3254.7527.8827.78
PS Ratio
13.318.5910.5910.409.8810.64
PB Ratio
6.343.944.434.543.765.21
P/TBV Ratio
8.004.685.335.244.386.98
P/FCF Ratio
265.3561.42211.6197.4243.0239.81
P/OCF Ratio
51.0629.0742.4637.3225.5021.20
PEG Ratio
-1.031.031.031.031.03
EV/Sales Ratio
12.848.1510.079.528.8310.41
EV/EBITDA Ratio
48.4131.2937.9537.9533.8451.59
EV/EBIT Ratio
74.9547.7959.9158.6253.5793.03
EV/FCF Ratio
255.8958.22201.2489.1638.4638.93
Debt / Equity Ratio
0.030.020.010.030.010.07
Debt / EBITDA Ratio
0.220.130.070.240.100.71
Debt / FCF Ratio
1.140.240.380.560.110.53
Net Debt / Equity Ratio
-0.24-0.31-0.27-0.42-0.40-0.12
Net Debt / EBITDA Ratio
-1.96-2.60-2.40-3.80-4.03-1.25
Net Debt / FCF Ratio
-10.21-4.83-12.70-8.93-4.58-0.94
Asset Turnover
0.400.400.350.370.380.37
Inventory Turnover
2.182.282.062.082.001.90
Quick Ratio
2.343.093.402.563.881.49
Current Ratio
3.153.624.072.944.351.94
Return on Equity (ROE)
7.79%7.20%7.25%7.92%7.75%0.82%
Return on Assets (ROA)
4.29%4.30%3.69%3.72%3.90%2.61%
Return on Invested Capital (ROIC)
11.04%10.95%9.69%10.60%9.13%5.11%
Return on Capital Employed (ROCE)
7.60%7.30%6.60%6.90%6.10%5.30%
Earnings Yield
1.19%1.75%1.63%1.76%1.77%0.21%
FCF Yield
0.38%1.63%0.47%1.03%2.33%2.51%
Dividend Yield
0.98%1.64%1.58%1.59%1.56%-
Payout Ratio
83.01%90.77%94.71%69.25%2.91%878.69%
Buyback Yield / Dilution
-0.88%0.13%-1.55%-2.90%-5.23%3.55%
Total Shareholder Return
0.11%1.77%0.02%-1.31%-3.67%3.55%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.